JMD Conference & Exhibition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz, L. K.
Right arrow Articles by Gilcrease, M. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz, L. K.
Right arrow Articles by Gilcrease, M. Z.
JMD 2004, Vol. 6, No. 1
Copyright © 2004 American Society for Investigative Pathology & Association for Molecular Pathology

Chromogenic In Situ Hybridization for {alpha}6ß4 Integrin in Breast Cancer

Correlation with Protein Expression

Leslie K. Diaz, Xiao Zhou, Kristin Welch, Aysegul Sahin and Michael Z. Gilcrease

From the Department of Pathology, M.D. Anderson Cancer Center, Houston, Texas


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The {alpha}6ß4 integrin is the receptor for the basement membrane protein laminin-5. Recent studies suggest that {alpha}6ß4 integrin expression in invasive breast carcinomas may be a poor prognostic factor. Because we have not had reliable results with commercially available antibodies for the immunohistochemical detection of {alpha}6ß4 integrin in archival paraffin-embedded tissues, we designed a probe to detect ß4 integrin subunit mRNA in paraffin sections. In situ hybridization for ß4 mRNA was performed on paraffin-embedded tissue sections of 25 invasive breast carcinomas using a hyperbiotinylated oligonucleotide DNA probe. Immunohistochemical staining was performed on corrresponding frozen tumor sections using two commercially available antibodies to the ß4 integrin subunit. All cases positive for ß4 protein by one or both antibodies were also positive for ß4 mRNA by in situ hybridization, but three cases with ß4 mRNA expression were negative by immunohistochemistry with both antibodies. These findings suggest that in situ hybridization appears to be a sensitive method for detecting ß4 integrin mRNA, but it appears to identify some cases that either lack ß4 protein or express variants not recognized with commercial antibodies directed to particular extracellular or cytoplasmic domains.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Integrins are glycoprotein heterodimers that serve as the principal cell surface receptors for extracellular matrix proteins.1, 2, 3, 4 Each integrin heterodimer is composed of a single {alpha} and a single ß subunit. At present, 18 {alpha} subunits and eight ß subunits have been identified. The ß4 subunit associates exclusively with {alpha}6. There has been particular interest recently in the {alpha}6ß4 integrin, a receptor for some of the isoforms of laminin, because of its unique signaling properties and its putative role in tumor cell invasion and metastasis.5, 6, 7, 8, 9, 10

A number of lines of evidence support the hypothesis that {alpha}6ß4 expression plays a role in tumor invasion and metastasis. Two previous studies from Italy and Germany demonstrated a strong correlation between {alpha}6ß4 expression in breast cancer and reduced patient survival.11, 12 Similarly, reduceddisease-free survival for tumors with {alpha}6ß4 expression was recently reported in patients with squamous cell carcinoma of the head and neck.13

The immunohistochemical evaluation of {alpha}6ß4 integrin expression in patient specimens has been hampered to date by the lack of available antibodies that show reproducible immunohistochemical staining results in archival paraffin-embedded tissue sections. The few studies published so far have used frozen tissue specimens11, 12, 13 or fixation methods different from those routinely used on clinical specimens,14 so the number of specimens with long clinical follow-up has been limited. In this study, we designed an oligonucleotide probe for the colorimetric detection of ß4 integrin subunit mRNA in formalin-fixed, paraffin-embedded sections of invasive breast carcinomas and compared ß4 mRNA expression with immunohistochemical staining results on corresponding frozen tissue sections.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Cell Culture
Breast carcinoma cell lines MDA-MB-231 and MDA-MB-134 were obtained from the laboratory of Dr. Janet Price, Department of Cancer Biology at M. D. Anderson Cancer Center, where they were previously characterized by flow cytometry as {alpha}6ß4 positive and {alpha}6ß4 negative, respectively.15 The cell lines were cultured in Eagle’s minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), L-glutamine, sodium pyruvate, and nonessential amino acids and vitamins (Gibco, Grand Island, NY). The cells were maintained in monolayer culture in a humidified incubator at 37°C in an atmosphere of 5% CO2 and 95% air.

Tissues
Twenty-five frozen cases of invasive breast carcinoma that had corresponding paraffin-embedded tissue blocks available were selected from the M. D. Anderson Breast Tumor Bank. Twenty-three of the invasive breast carcinomas were of ductal type, one was ductal type with mucinous features, and one was a mixed ductal and lobular carcinoma. Seventeen of the cases were of nuclear grade 3 (high) and eight were of nuclear grade 2 (intermediate). The frozen tissues were procured from fresh surgical resection specimens and snap-frozen in OCT. Corresponding formalin-fixed, paraffin-embedded tumor blocks were retrieved from the surgical pathology files of M. D. Anderson Cancer Center.

Immunohistochemistry
Cytospin preparations were made of each cell line, and 5-µm sections were cut from the frozen tissue. The cytospins and frozen tissue sections were fixed in cold acetone for 5 minutes and air-dried. Immunohistochemical staining was performed using two different antibodies against the ß4 integrin subunit: a commercially available rabbit polyclonal antibody directed against a synthetic peptide with the sequence NH2-(K)GTLSTHMDQQFFQT-amide derived from the cytoplasmic domain of ß4 (1:1000, Chemicon, Temecula, CA); and a monoclonal antibody derived against a prokaryotic recombinant protein corresponding to part of the extracellular domain (clone ELF1, 1:50, Novocastra, Burlingame, CA). Immunohistochemical staining was performed using the Vector ABC kit and a standard avidin-biotin peroxidase method. Tumors were considered positive if they exhibited immunohistochemical staining in 5% or more of the tumor cells.

Probes
An oligonucleotide probe was designed to recognize a portion of the cytoplasmic domain of the ß4 integrin subunit common to splice variants ß4A, ß4B, ß4C, and ß4D (Figure 1)Go .4 The 40-mer oligonucleotide probe had a GC content of 56.1% and the following sequence:



View larger version (29K):
[in this window]
[in a new window]
  		Figure 1. Splice variants of the ß4 integrin subunit. The ß4 probe recognizes a 40-nucleotide sequence in the connecting segment between the two pairs of fibronectin type III repeats in a region that does not overlap with the insertions for variants ß4B and ß4C.

 
5'-GTAGTCCCTGGGCAGTGTGGTCGAGTGTGAGTGTT-CTGAG-3'. The custom probe was purchased from Research Genetics (Huntsville, AL), where it was conjugated with a 3' hyperbiotinylated tail. A polyd(T) 20-oligonucleotide probe was also purchased from Research Genetics.

In Situ Hybridization
Histological sections from the paraffin blocks were cut at 4 µm intervals using RNase-free conditions (all instruments, glassware, and slides washed overnight in 0.1% DEPC water, and histological sections cut using a 0.1% DEPC water bath). Tissue sections were mounted on silane-treated ProbeOn slides (Fisher Scientific, Pittsburgh, PA) and pre-heated at 65° for 45 minutes before beginning the assay. In situ hybridization was performed using the Microprobe System (Fischer Scientific, Pittsburgh, PA) and the chromagen Fast Red (Biomeda Corp., Foster City, CA) as previously described.16, 17 Briefly, the glass slides were placed into the Microprobe holder, and paraffin sections were dewaxed with Autodewaxer and dehydrated using Autoalcohol (Research Genetics). This was followed by digestion with Pepsin Reagent (Fisher Scientific) for 4 minutes at 100°C. Sections were hybridized with probe at 45°C for 1 hour, then washed three times at 45°C with 0.3 M NaCl and 0.03 M sodium citrate. Incubation with chromogen was performed at 45°C for 30 minutes, followed by an additional incubation for 10 minutes. Phosphatase Enhancer Reagent (Fisher Scientific) was applied to the samples for 1 minute before both incubations with chromagen. The same procedure was performed on the cytospin preparations, with the exception of the dewaxing and dehydration steps. Tumors were considered positive if they exhibited hybridization signal in 5% or more of the tumor cells. In situ hybridization with the polyd(T) probe was performed on each specimen to verify the integrity of mRNA, and competition with a 100-fold excess of unlabeled probe was performed on representative slides to demonstrate specificity of the ß4 probe.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Immunohistochemical staining for ß4 protein confirmed ß4 expression in the breast cancer cell line MDA-MB-231 and the absence of ß4 in MDA-MB-134 (Figure 2 A and B)Go . In situ hybridization detected ß4 integrin subunit mRNA in the MDA-MB-231 cells but not in the MDA-MB-134 cells (Figure 2 C and D)Go , and competition with excess unlabeled probe confirmed specificity of the ß4 probe.



View larger version (48K):
[in this window]
[in a new window]
  		Figure 2. Immunohistochemical staining for ß4 protein in breast cancer cell lines MDA-MB-231 (A) and MDA-MB-134 (B) (magnification, x400; immunoperoxidase with DAB chromogen). In situ hybridization for ß4 integrin subunit mRNA in MDA-MB-231(C) and MDA-MB-134 (D) (magnification, x400; alkaline phosphatase with Fast Red chromogen).

 
In situ hybridization detected ß4 integrin subunit mRNA in 15 of the 25 formalin-fixed, paraffin-embedded breast carcinoma specimens (Table 1)Go . Positive cases showed heterogeneous expression of ß4 mRNA, with some areas of the tumors showing much greater expression than other areas. In situ hybridization produced a granular red staining reaction within the cytoplasm of tumor cells (Figure 3A)Go . The cytoplasm of endothelial cells also showed a positive signal and served as an internal control. Competition with 100-fold excess of unlabeled probe almost completely abolished the signal, indicating specificity of the ß4 probe (Figure 3B)Go .


View this table:
[in this window]
[in a new window]
  		Table 1. Comparison of In Situ Hybridization (ISH) and Immunohistochemical (IHC) Staining Results for ß4 Integrin Subunit in Invasive Breast Carcinoma Specimens

 


View larger version (110K):
[in this window]
[in a new window]
  		Figure 3. In situ hybridization for ß4 integrin subunit mRNA in a paraffin-embedded, formalin-fixed section of invasive ductal carcinoma (A), and competition with 100-fold excess of unlabeled probe (B) (magnification, x200; alkaline phosphatase with Fast Red chromogen).

 
Using the polyclonal antibody directed against a cytoplasmic ß4 epitope, immunohistochemical stains on the frozen sections were positive in 10 of the cases found to be positive for ß4 mRNA by in situ hybridization. Tumor cells positive for ß4 protein exhibited staining diffusely throughout the cytoplasm (Figure 4)Go . With the monoclonal antibody directed against an extracellular epitope of ß4, 10 cases were positive by immunohistochemical staining, eight of which were the same as those that were positive with the polyclonal antibody to the cytoplasmic domain. Neither of the antibodies detected ß4 protein expression in cases that were negative for ß4 mRNA by in situ hybridization (Table 1)Go .



View larger version (117K):
[in this window]
[in a new window]
  		Figure 4. Immunohistochemical staining for ß4 protein in a frozen section of invasive ductal carcinoma (magnification, x200; immunoperoxidase with DAB chromogen).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The extracellular matrix comprises an extensive network of proteins that, in part, provide structural properties of tissues. In addition, the interactions between extracellular matrix proteins and their cell surface receptors provide cross-talk between the cells and their extracellular environment.18 As extracellular matrix protein receptors, integrins mediate a complex array of mechanical and biochemical signals. Most integrins contain a short cytoplasmic tail and participate in intracellular signaling by associating with various adaptor proteins. On ligand stimulation, integrins typically localize to particular sites in the cell membrane referred to as focal adhesions, and the formation of focal adhesions promotes the assembly of actin filaments.18 In contrast, the ß4 integrin subunit contains a long cytoplasmic tail, interacts with keratin filaments rather than actin filaments, and participates in the formation of hemidesmosomes.19, 20

Recent exciting data suggests that {alpha}6ß4-mediated signal transduction plays an important role in tumor invasion and metastasis.6, 7, 8, 9, 10 The mechanisms whereby {alpha}6ß4 expression may lead to increased invasive or metastatic behavior are unknown, but new information about {alpha}6ß4 integrin signaling pathways is beginning to shed some light on this subject. On binding laminin-5, one of the principal ligands for {alpha}6ß4, the ß4 subunit becomes phosphorylated and subsequently activates downstream signaling pathways.5, 7, 10, 21 Tumor cell invasion involves the formation of actin-containing motility structures such as lamellae and filopodia. It has been shown that {alpha}6ß4 is localized in lamellae and filopodia of invasive tumor cells,22 and the formation of these structures is dependent on phosphatidylinositol 3-OH kinase (PI3K).10 Moreover, the {alpha}6ß4 integrin appears to preferentially activate PI3K.9

Immunohistochemical staining for ß4 protein in frozen sections of normal breast tissue show it to be expressed in the myoepithelial cell layer of normal ducts and lobules (personal observation). The myoepithelial cell layer is in contact with the extracellular basement membrane, which is known to contain laminin-5, the principal ligand for {alpha}6ß4. The luminal epithelial cell layer of normal ducts, however, does not show {alpha}6ß4 expression by immunohistochemistry (personal observation). Since most invasive breast cancers show a morphological and immunohistochemical phenotype more like the luminal epithelial cells than the myoepithelial cells,23 those tumors that show {alpha}6ß4 expression should be regarded as having overexpression of this integrin. In this regard, {alpha}6ß4-positive breast carcinomas acquire a receptor for extracellular matrix that their non-neoplastic counterparts, the luminal ductal epithelial cells, do not express. This may play an important role in allowing the tumor cells to invade the stroma and to metastasize.

The immunohistochemical evaluation of {alpha}6ß4 integrin expression in patient specimens has been hampered by the lack of available antibodies that show reproducible staining results on archival paraffin-embedded tissue sections. Hanby et al14 reported successful immunohistochemical staining for ß4 on tissues fixed in formalin at 4°C, but they did not see staining when tissues were fixed at room temperature (the temperature at which most archival tissues are fixed). We have made many attempts to use such antibodies against the {alpha}6 and ß4 subunits on formalin-fixed, paraffin-embedded tissue sections following various antigen-retrieval methods without success to date.

As a cross-linking fixative, formalin preserves tissues and inactivates cellular enzymes by cross-linking enzymes and other proteins not only to each other but to RNA and DNA as well. When RNA is complexed in this way, it is less accessible to RNase degradation. Despite initial concerns about the degradation of RNA in fixed tissue sections, experience has shown in situ hybridization to be a powerful method for evaluating gene expression in archival tissues.24, 25, 26, 27

The immunohistochemical staining results obtained with the antibody directed against the extracellular domain of ß4 were different from those obtained with the antibody against a portion of the cytoplasmic domain, but all cases positive for ß4 protein by one or both antibodies were positive for ß4 mRNA by in situ hybridization on the paraffin sections. This observation suggests that the ß4 protein (or a variant thereof) in some tumors is not detected with particular commercially available antibodies to ß4. Three cases were positive by in situ hybridization but negative by immunohistochemistry with both antibodies. In situ hybridization, therefore, appears to be a sensitive method for detecting ß4 integrin mRNA in archival tissues, but it appears to identify some cases that either lack ß4 protein or express variants not recognized with commercial antibodies directed to particular extracellular or cytoplasmic domains.28, 29

In the absence of reliable immunohistochemistry for detection of ß4 protein in archival formalin-fixed, paraffin-embedded tissues, the use of an oligonucleotide probe to detect ß4 mRNA in archival tissues could allow a large number of invasive breast carcinomas with corresponding clinical follow-up data to be evaluated. This would have many advantages over the use of frozen tissue samples for immunohistochemical analyses. A larger number of archival cases would be available for evaluation, expression of {alpha}6ß4 in metastases could be compared to its expression in the corresponding primary breast tumors, and possible ß4 variants not recognized by particular antibodies could be detected with the probe for ß4 mRNA. Although ß4 mRNA expression may not correlate with functional ß4 protein expression in all cases, in situ hybridization may nevertheless be useful to determine whether ß4 mRNA expression has any prognostic or predictive value in invasive breast carcinoma.


   Acknowledgments
 
We thank Dr. Janet Price, Department of Cancer Biology at M.D. Anderson Cancer Center, for providing the breast carcinoma cell lines.


   Footnotes
 
Address reprint requests to Michael Z. Gilcrease, M.D., Ph.D., Department of Pathology, M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. E-mail: mgillcre{at}mdanderson.org

Supported in part by Career Development Award DAMD17–01-1–0298 from the U.S. Department of Defense (to M.Z.G.).

Accepted for publication November 6, 2003.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Keely P, Parise L, Juliano R: Integrins and GTPases in tumour cell growth, motility, and invasion. Trends Cell Biol 1998, 8:101-106[Medline]
  2. Varner JA, Cheresh DA: Integrins and cancer. Curr Opin Cell Biol 1996, 8:724-730[Medline]
  3. Hughes PE, Pfaff M: Integrin affinity modulation. Trends Cell Biol 1998, 8:359-364[Medline]
  4. Melker AA de, Sonnenberg A: Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events. Bioessays 1999, 21:499-509[Medline]
  5. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM: Integrin {alpha}6ß4 regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 2002, 158:165-174[Abstract/Free Full Text]
  6. Rabinovitz I, Gipson IK, Mercurio AM: Traction forces mediated by {alpha}6ß4 integrin: implications for basement membrane organization and tumor invasion. Mol Biol Cell 2001, 12:4030-4043[Abstract/Free Full Text]
  7. Shaw LM: Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the {alpha}6ß4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 2001, 21:5082-5093[Abstract/Free Full Text]
  8. Mercurio AM, Rabinovitz I, Shaw LM: The {alpha}6ß4 integrin and epithelial cell migration. Curr Opin Cell Biol 2001, 13:541-545[Medline]
  9. Gambaletta D, Marchetti A, Benedetti L, Mercurio AM, Sacchi A, Falcioni R: Cooperative signaling between {alpha}(6)ß(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 2000, 275:10604-10610[Abstract/Free Full Text]
  10. Shaw LM, Rabinovitz I, Wang HH-F, Toker A, Mercurio AM: Activation of phosphoinositide 3-OH kinase by the {alpha}6ß4 integrin promotes carcinoma invasion. Cell 1997, 91:949-960[Medline]
  11. Friedrichs K, Ruis P, Franke F, Gille I, Terpe HJ, Imhof BA: High expression level of {alpha}6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995, 15:901-906
  12. Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Menard S: Prognostic value of {alpha}6ß4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res 1998, 4:407-410[Abstract/Free Full Text]
  13. Wolf GT, Carey TE, Schmaltz SP, McClathey KD, Poore J, Glaser L, Hayashida DJS, Hsu S: Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1990, 82:1566-1572[Abstract/Free Full Text]
  14. Hanby AM, Gillett CE, Pignatelli M, Stamp GWH: ß 1 and ß 4 integrin expression in methacarn and formalin-fixed material from in situ ductal carcinoma of the breast. J Pathol 1993, 171:257-262[Medline]
  15. Mukhopadhyay R, Theriault RL, Price JE: Increased levels of {alpha}6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clin Exp Metastasis 1999, 17:325-332[Medline]
  16. Leary JJ, Brigati DJ, Ward DC: Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: bio-blots. Proc Natl Acad Sci USA 1983, 80:4045-4049[Abstract/Free Full Text]
  17. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary KR, Brigati DJ, Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res 1993, 53:937-943[Abstract/Free Full Text]
  18. Slade MJ, Coope RC, Gomm JJ, Coombes RC: The human mammary gland basement membrane is integral to the polarity of luminal epithelial cells. Exp Cell Res 1999, 247:267-278[Medline]
  19. Spinardi L, Ren Y-L, Sanders R, Giancotti FG: The ß4 subunit cytoplasmic domain mediates the interaction of {alpha}6ß4 integrin with the cytoskeleton of hemidesmosomes. Mol Biol Cell 1993, 3:871-884
  20. Spinardi L, Einheber S, Cullen T, Milner TA, Giancotti FG: A recombinant tail-less integrin ß 4 subunit disrupts hemidesmosomes, but does not suppress {alpha}6ß4-mediated cell adhesion to laminins. J Cell Biol 1995, 129:473-487[Abstract/Free Full Text]
  21. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137:481-492[Abstract/Free Full Text]
  22. Rabinovitz I, Mercurio AM: The integrin {alpha}6ß4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol 1997, 139:1873-1884[Abstract/Free Full Text]
  23. Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR: CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001, 85:422-427[Medline]
  24. Guitteny AF, Fouque B, Mongin C, Teoule R, Boch B: Histologic detection of mRNA with biotinylated synthetic oligonucleotide probes. J Histochem Cytochem 1988, 36:563-571[Abstract]
  25. Farquharson M, Harvie R, McNicol AM: Detection of mRNA using a digoxigenin end-labeled oligodeoxynucleotide probe. J Clin Pathol 1990, 43:424-428[Abstract/Free Full Text]
  26. Camp RL, Charette LA, Rimm DL: Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000, 80:1943-1949[Medline]
  27. Hoos A, Urist MJ, Stojadinovic A, Mastorides S, Dudas M, Kuo D, Leung DHY, Brennan MF, Lewis JJ, Cordon-Cardo C: Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001, 158:1245-1251[Abstract/Free Full Text]
  28. Clarke AS, Lotz MM, Mercurio A: A novel structural variant of the human ß4 integrin cDNA. Cell Adhes Commun 1994, 2:1-6[Medline]
  29. van Leusden MR, Kuikman I, Sonnenberg A: The unique cytoplasmic domain of the human integrin variant ß4E is produced by partial retention of intronic sequences. Biochem Biophys Res Commun 1997, 235:826-830[Medline]



This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
P. Carter, L. Smith, and M. Ryan
Identification and validation of cell surface antigens for antibody targeting in oncology
Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz, L. K.
Right arrow Articles by Gilcrease, M. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz, L. K.
Right arrow Articles by Gilcrease, M. Z.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS